BackResponse Genetics Overview

Response Genetics Total Assets

Track Response Genetics's total assets ($11M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$10.78M
↓ 24.93% YoYΔ $-3.58M vs prior year quarter

Peer trimmed avg / median

Loading

Response Genetics Total Assets History

Loading

Response Genetics vs. peers: Total Assets Comparison

Loading

Response Genetics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Response Genetics (RGDXQ) FAQ

As of the most recent data (March 2015), RGDXQ shows a total assets of $11M. That compares with $14M in the prior-year period — down 24.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RGDXQ's total assets is now $11M (was $14M) — a 24.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Response Genetics is outperforming or lagging.

Tracking RGDXQ's total assets over time shows whether Response Genetics is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $14M in the prior-year period — down 24.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Response Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $11M) with ownership activity and broader fundamentals.